Term: adalimumab
IPA: ˌeɪ.dəˈlɪm.jəˌmæb

==English==
{{wp}}

===Etymology===
From {{af|en|ada-|-lim-|-umab|qq1=of unknown origin|t2=immunomodulating|t3=human monoclonal antibody|nocat=1}}.

===Pronunciation===
* {{IPA|en|/ˌeɪ.dəˈlɪm.jəˌmæb/|a=GA}}

===Noun===
{{en-noun|-}}

# {{lb|en|pharmaceutical drug}} An [[immunosuppressive]] drug (trademark '''Humira''') that is a [[genetically engineered]] [[monoclonal antibody]] administered by [[subcutaneous]] [[injection]] to treat the symptoms of various [[autoimmune]] diseases (such as [[rhe